Experimental Gonococcal Infection in Male Volunteers: Cumulative Experience with Neisseria gonorrhoeae Strains FA1090 and MS11mkC by Hobbs, Marcia M. et al.
REVIEW ARTICLE
published: 3 May 2011
doi: 10.3389/fmicb.2011.00123
Experimental gonococcal infection in male volunteers:
cumulative experience with Neisseria gonorrhoeae strains
FA1090 and MS11mkC
Marcia M. Hobbs
1,2*, P . Frederick Sparling
1,2, Myron S. Cohen
1,2,William M. Shafer
3,4, Carolyn D. Deal
5 and
Ann E. Jerse
6
1 Departments of Medicine, University of North Carolina, Chapel Hill, NC, USA
2 Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA
3 Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA
4 Laboratories of Bacterial Pathogenesis, Veterans Affairs Medical Center (Atlanta), Decatur, GA, USA
5 National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
6 Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
Edited by:
Cynthia N. Cornelissen, Virginia
Commonwealth University School of
Medicine, USA
Reviewed by:
Stanley Spinola, Indiana
University–Purdue University at
Indianapolis, USA
Catherine Ann Ison, Health Protection
Agency, UK
*Correspondence:
Marcia M. Hobbs, Department of
Medicine, University of North
Carolina, CB# 7031, Chapel Hill, NC
27599, USA.
e-mail: mmhobbs@med.unc.edu
Experimental infection of male volunteers with Neisseria gonorrhoeae is safe and repro-
duces the clinical features of naturally acquired gonococcal urethritis. Human inoculation
studies have helped deﬁne the natural history of experimental infection with two well-
characterized strains of N. gonorrhoeae, FA1090 and MS11mkC. The human model has
proved useful for testing the importance of putative gonococcal virulence factors for ure-
thral infection in men. Studies with isogenic mutants have improved our understanding
of the requirements for gonococcal LOS structures, pili, opacity proteins, IgA1 protease,
and the ability of infecting organisms to obtain iron from human transferrin and lactoferrin
during uncomplicated urethritis.The model also presents opportunities to examine innate
host immune responses that may be exploited or improved in development and testing of
gonococcal vaccines. Here we review results to date with human experimental gonorrhea.
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INTRODUCTION
In nature, gonococcal infection is strictly limited to the human
host. Uncomplicated infection can be asymptomatic or mani-
fest as urethritis in men and cervicitis in women. Complications
resulting from tissue invasion include orchitis, epididymitis and
pelvic inﬂammatory disease, and systemic dissemination can lead
to arthritis, tenosynovitis, or dermatitis. Like other inﬂamma-
tory mucosal infections, gonorrhea also facilitates HIV transmis-
sion and acquisition. Treatment options for gonococcal infection
are dwindling as worldwide, Neisseria gonorrhoeae is becoming
increasingresistanttocurrentlyavailableantibiotics(Lewis,2010).
Experimentalhumanurethralinfectionoffersthepotentialtobet-
ter understand the contributions of microbial factors and host
immune responses to infection that may eventually translate into
the development of an effective gonococcal vaccine and provides
an appropriate model for vaccine testing.
The use of live N. gonorrhoeae to cause experimental infection
has a long and sometimes sordid history dating back to the late
eighteenth century when British surgeon John Hunter repeatedly
inoculatedpatientswith“venerealmatter”totestwhethervenereal
disease was infectious (Hunter, 1835). Recent reports of experi-
mental gonorrhea studies conducted during the 1940s in vulner-
able populations who were often deceived and infected without
informed consent highlight the ethical issues that surround clini-
cal research with human subjects (Frieden and Collins,2010); the
issuesareparticularlysensitiveforexperimentalhumaninfections
with sexually transmitted pathogens. All of the studies described
hereinweresubjecttorigoroussafetyandethicalreviewbyappro-
priate Institutional Review Boards.Written informed consent was
obtainedfromallsubjectsinaccordancewiththeethicalprinciples
setforthintheDeclarationof HelsinkiandtheUSCodeof Federal
Regulations for the Protection of Human Subjects. Several hun-
dred subjects have participated in experimental infection studies
without reported complications or adverse events.
EXPERIMENTAL MODEL
Experimental gonorrhea is restricted to male subjects; women
cannot safely be included due to potential complications from
ascendant gonococcal infection. Inoculation is accomplished by
the instillation of 0.2–0.3mL of a gonococcal suspension through
a pediatric catheter inserted approximately 5cm into the ure-
thra. There are slight variations in the preparation and delivery of
experimental inocula used in previously published work detailed
by Cohen and Cannon (1999), Cohen et al. (1994), and Schmidt
et al. (2001). Following inoculation, infection can be monitored
by bacterial recovery from urogenital specimens including urine,
urethral swabs and semen. Gonococcal urethritis is deﬁned by
the development of urethral discharge containing gram negative
diplococci or recovery of gonococci from a urethral swab culture.
Host responses can be monitored by enumeration of white blood
cells in urine and urethral exudates and measurement of soluble
immune mediators including antibodies and cytokines in urine
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and serum. Clinical disease is monitored by daily physical exam-
ination. Subjects receive prompt effective antibiotic treatment as
soon as infection is clinically apparent,when requested because of
intolerance for symptoms or at the end of the experimental trial,
up to 7days after inoculation, regardless of whether or not the
subject was judged to be infected during the trial.
Two gonococcal strains, N. gonorrhoeae FA1090 and
MS11mkC,have been used in the majority of experimental infec-
tion studies conducted over the past 20years. FA1090 is a porin
serotype PIB-3 strain originally isolated in the 1970s from the
endocervix of a woman with probable disseminated gonococcal
infection (Nachamkin et al., 1981) and has been used extensively
in experimental infection studies conducted at the University of
NorthCarolinaatChapelHill(Cohenetal.,1994;Jerseetal.,1994;
Seifert et al., 1994; Cornelissen et al., 1998; Cohen and Cannon,
1999;Johannsenetal.,1999).MS11isaporinserotypePIB-9strain
originallyisolatedin1970fromapatientwithuncomplicatedante-
riorurethritis(Edwardsetal.,1984;Swansonetal.,1985).MS11mk
is descended from MS11, and MS11mkC is a lipooligosaccharide
(LOS) variant isolated from an experimentally infected male vol-
unteer in the late 1980s (Schneider et al., 1991). MS11mkC was
usedinsubsequentvolunteerstudiesconductedattheWalterReed
Army Institute of Research (Ramsey et al., 1995; Schneider et al.,
1995,1996; Schmidt et al., 2000,2001).
N. GONORRHOEAE MS11mkC IS MORE INFECTIOUS THAN
FA1090 IN THE MALE URETHRA
Too few subjects can be included in individual experimental trials
to reliably evaluate the infectivity of a given inoculum. However,
the cumulative experience to date includes sufﬁcient numbers of
subjects and a wide enough range of doses to estimate the rel-
ative infectivities of the two strains. We analyzed available data
from 55 men inoculated with wild-type MS11mkC at doses from
2.5×102 to 5.7×104 colony-forming units (cfu; Schneider et al.,
1995; Schmidt et al., 2001 and unpublished data from J. G. Can-
non) and 43 men inoculated with wild-type FA1090 at doses from
1.0×104 to 3.5×106 cfu (Cohen et al., 1994 and unpublished
data from J. G. Cannon and M. M. Hobbs). We conducted mul-
tiple logistic regression analyses using SigmaStat version 3.5 for
Windows (Systat Software, Inc., Point Richmond, CA, USA) to
predict the probability of infection over a range of doses for each
strain (Figure 1). The quality of the ﬁt for each dose response
curve was tested using the Hosmer–Lemeshow statistic (Hosmer
and Lemeshow, 2000). A non-signiﬁcant P value (>0.05) indi-
cates a good ﬁt between the logistic equation and the raw data;
P =0.369 for MS11mkC, and P =0.878 for FA1090. The esti-
mated dose resulting in infection of 50% of inoculated subjects
(ID50)is1.8×103 cfuforMS11mkCand1.0×105 cfuforFA1090.
Similar differences in infectivity for the two strains have been
observed in the murine model of female genital tract infection
(Jerse, 1999).
The reasons for the apparent nearly 2 log10 difference in ID50
betweenFA1090andMS11mkCforurethralinfectionarenotclear.
Greatcarehasbeentakentodescribeandcontrol(asmuchaspos-
sible)theexpressionof recognizedphase-variabledeterminantsin
experimental inocula. Inoculum variants of both strains used in
theexperimentalinfectionsincludedinthedoseresponseanalyses
FIGURE 1 | Neisseria gonorrhoeae strain MS11mkC is more infectious
than strain FA1090 in experimental infection of the male urethra.
Multiple logistic regression analysis was used to generate dose response
models with data from 55 men inoculated with MS11mkC (dashed line) and
43 men inoculated with FA1090 (solid line). All inocula contained
predominantly piliated, Opa-negative, wild-type gonococci.The estimated
ID50 (indicated by the horizontal dotted line) is 1.8×10
3 cfu for MS11mkC
and 1.0×10
5 cfu for FA1090.
contained predominantly piliated (P+),Opacity protein-negative
(Opa−) gonococci expressing the lacto-N-neotetraose LOS epi-
tope recognized by monoclonal antibody (Mab) 3F11, which is
associated with the development of urethral discharge in nat-
urally acquired and experimental gonococcal infection in men
(Schneideretal.,1991).StrainsFA1090andMS11havebeenexten-
sively characterized in numerous laboratories,and there are many
recognized differences. Though not an exhaustive list, Table 1
summarizes some of the features that differ between FA1090 and
MS11mkC,potentially inﬂuencing infectivity in the experimental
model of urethral infection.
The relatively recent human passage of MS11mkC compared
to FA1090 may also have resulted in unrecognized differences
between the two strains. Though inocula prepared from both
strainshavebeendescribedaspiliated,itispossiblethatMS11mkC
is hyperpiliated compared to FA1090.
NATURAL HISTORY OF EXPERIMENTAL INFECTION WITH
WILD-TYPE GONOCOCCI
Despitetheapparentdifferenceininfectivity,thecourseof experi-
mental infection and development of clinical signs and symptoms
caused by wild-type piliated, Opa-negative inocula of N. gon-
orrhoeae strains FA1090, and MS11mkC are very similar. The
clinical and microbiological courses of infection in individual
infected subjects have been described previously (Schneider et al.,
1991, 1995, 1996; Cohen et al., 1994; Jerse et al., 1994; Cohen
and Cannon, 1999; Schmidt et al., 2001) and are summarized
here. Gonococci are recovered at low levels in urine from most
subjects 2h after inoculation. A so-called eclipse period of vari-
able length ensues during which few or no viable gonococci
are recovered from urine. Then, infected individuals begin to
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Table 1 | Recognized differences between N. gonorrhoeae strains FA1090 and MS11mkC.
Characteristic FA1090 MS11mkC References
Serum susceptibility Resistant Sensitive (characterized as
Intermediate by some)
Cohen et al. (1994),
Ram et al. (2001)
Gonococcal genetic island Absent Present Dillard and Seifert, (2001)
Lactoferrin utilization (expression of
lactoferrin-binding proteins B and A)
Lf− (LbpB-A−)L f + (LbpB-A+) Anderson et al. (2003)
Mtr efﬂux pump expression Not inducible due to 11bp deletion
in the coding region of activator
mtrA;w tmtrCDE promoter
Inducible with wt mtrA;
higher expression of pump
due to novel mtrCDE
promoter and missense
mutation in repressor mtrR
Rouquette et al. (1999), Warner
et al. (2008), and W. M. Shafer
(unpublished data)
Lf, lactoferrin; Lbp, lactoferrin-binding protein; Mtr, multiple transferable resistance; bp, base pair; wt, wild-type.
shed increasing numbers of organisms in the urine, though the
number of gonococci recovered from infected subjects does not
correlate with the severity of infection. Bacteriuria persists until
signs and symptoms of infection including dysuria and urethri-
tis develop. Most men experimentally infected with wild-type
gonococci develop gonococcal disease characterized by a urethral
discharge and dysuria, consistent with the clinical presentation
of naturally acquired gonorrhea. The incubation period between
inoculation and development of signs or symptoms of infection is
variable,ranging from 1 to 6days for both FA1090 and MS11mkC
and is independent of the number of gonococci in the inoculum.
Thoughrare,asymptomaticexperimentalinfectionwithwild-type
FA1090 variants occurs and is characterized by recovery of gono-
cocci from urine in the absence of signs or symptoms during the
5- to 6-day trial period (J. G. Cannon and A. E. Jerse, unpub-
lished data); asymptomatic infection with MS11mkC has not
been reported.
Cellular and soluble mediators of the host response to exper-
imental infection follow a similar pattern. Pyuria, as determined
by the presence of white blood cells in urine sediment (Cohen
et al., 1994; Ramsey et al., 1995), and elevated urinary interleukin
(IL)-6 and IL-8 (Ramsey et al., 1995) are frequently observed
within the ﬁrst 24h after inoculation. Whether the early appear-
ance of these inﬂammatory mediators is the result of mild irri-
tation caused by the insertion of the catheter during inoculation
or a direct response to gonococci is not clear. In subjects who
remain uninfected, pyuria resolves (Cohen et al., 1994; Ramsey
et al., 1995), and cytokines quickly return to pre-challenge lev-
els (Ramsey et al., 1995). Pyuria persists in infected subjects, and
the numbers of white blood cells in urine generally increase until
mendevelopsymptomsandrequiretreatment(Cohenetal.,1994;
Ramsey et al., 1995). Elevated levels of inﬂammatory cytokines
IL-6, IL-8, TNFα and IL-1β are consistently detected in urine in
response to experimental infection with MS11mkC or MS11mkA,
(an LOS variant lacking the 3F11 epitope; Schneider et al., 1991;
Ramsey et al., 1995); similar cytokine studies have not been con-
ducted with strain FA1090. The cytokine responses detected in
urine during experimental gonorrhea are comparable to those
seen during bacterial urinary tract infections (Sheu et al., 2006,
2007). During experimental gonococcal urethritis, inﬂammatory
host response indicators generally peak at the onset of symptoms
and return to pre-inoculation levels within 2days after treat-
ment (Ramsey et al., 1995). Elevated inﬂammatory cytokines in
peripheralcirculationarealsodetectedduringexperimentalinfec-
tion, returning to baseline after treatment. Cytokines in urine are
uniformly detectable in infected subjects with elevated plasma
cytokines.However,elevatedurinarycytokinelevelsintheabsence
of concomitant increases in plasma in some infected subjects sug-
gest local involvement in inﬂammatory responses to experimental
urethral infection (Ramsey et al., 1995).
Because experimentally infected subjects are treated at the
onset of signs or symptoms of infection, assessment of immune
responses is limited to those that occur during the early stages of
infection such as the innate immune responses described above.
Acquiredimmuneresponsesincludingproductionofspeciﬁcanti-
bodies are generally thought to require longer exposure than
occurs during experimental infection. However, Schneider and
colleaguesdemonstratedincreasesinserumIgGantibodiesrecog-
nizing gonococcal LOS in 8 of 14 subjects (57%) experimentally
infected for 3–7days with an ID90 of MS11mkC (Schmidt et al.,
2001). Interestingly, increased anti-LOS antibody titers were sig-
niﬁcantly associated with resistance to homologous reinfection,
though equivalent proportions of previously infected and naïve
subjects were infected with an ID50 challenge (Schmidt et al.,
2001).Menwhoexperiencedafourfoldorgreaterincreaseinanti-
LOS IgG titer during initial infection were more likely to resist
reinfection than men with lower and static LOS antibody titers
during initial infection. The mechanisms by which anti-LOS anti-
bodies in serum could protect from urethral gonococcal infection
are not clear. Increases in these circulating antibodies may be a
surrogate for protective mucosal immune responses,or transuda-
tion to the urethral mucosa could result from early inﬂammation
in experimental infection. Apicella and colleagues have shown
that gonococcal entry into primary human urethral epithelial
cells is dependent on LOS interactions with the asialoglycopro-
tein receptor (Harvey et al., 2001), and van Kooyk and colleagues
demonstrated that gonococcal LOS inﬂuences dendritic cell func-
tion and subsequent immune responses that promote bacterial
survival(vanVlietetal.,2009).Mucosalanti-LOSantibodiescould
interfere with these processes at very early stages of infection and
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potentially result in host immune responses that favor bacterial
clearance.
EXPRESSION AND ANTIGENIC VARIATION OF GONOCOCCAL
SURFACE STRUCTURES IN VIVO
The remarkable variation in surface structures expressed by dif-
ferent N. gonorrhoeae strains and the extraordinary plasticity of
the bacterial surface that an individual strain can present to its
infectedhostarehallmarksofthegonococcusthatlikelycontribute
to high rates of recurrent gonococcal infection. The frequent
modulation of bacterial surface determinants results from a com-
bination of phase variation (the switch between on and off states
of gene expression) and antigenic variation (the expression of dif-
ferent antigenic versions of a structure) that result in differential
expression of outer membrane components including pili, Opa
proteins, and LOS (reviewed in Edwards and Apicella, 2004). The
genetic mechanisms that result in phase and antigenic variation
have been extensively characterized (reviewed in Simms and Jerse,
2005), and in vitro models of gonococcal interactions with host
cells indicate that different antigenic versions of pilin (the major
pilussubunit),Opaproteins,andLOSrecognizedifferenthostcell
receptors, consistent with differential tissue tropism and patho-
genesis of naturally occurring gonococcal variants (Virji, 2009).
Phenotypic variation of these surface determinants occurs during
experimental infection in the male urethra.
LOS VARIATION AND MODIFICATION DURING EXPERIMENTAL
URETHRAL INFECTION
Productionof multipleLOSstructuresoccurswithinagonococcal
strain as well as within individual colonies of a given strain.Alter-
ations in LOS structures result from phase-variable production of
enzymes involved in extending carbohydrate structures from the
α- and β-chains of the core oligosaccharide. Variation in α-chain
residues is due to changes in polynucleotide repeat elements in
thelgtA,lgtC,andlgtD genes,encodingglycosyltransferases,orga-
nizedinanoperonthatalsoincludeslgtBandlgtE,whereasβ-chain
variation is due to alterations in a polynucleotide repeat in lgtG
(Banerjeeetal.,1998).ThedifferentLOSstructuresresultingfrom
“phase-on”or“phase-off”expressionofthesegenes,aswellasvari-
able modiﬁcations of the oligosaccharide core (e.g.,attachment of
phosphoethanolamine [PEA] to heptose I and II), can impact the
biologic properties of gonococci, altering bacterial susceptibility
to mediators of innate and acquired immune host defense and
attachment to host cells. A critical question is whether different
structures provide an advantage for gonococci during infection
andatdifferentstages(e.g.,beforeorafterdevelopmentof inﬂam-
mation).Theimportanceofthelacto-N-neotetraoseparaglobosyl
epitope of gonococcal LOS was recognized early in the history of
experimental infection with strain MS11mk. Following inocula-
tion of male volunteers with MS11mkA, which only produced a
3.6-kD lactosyl LOS and lacked higher molecular weight ganglio-
syl and paraglobosyl structures, gonococci isolated at the onset
of dysuria expressed gangliosyl LOS moieties, and bacteria iso-
lated at the onset of urethral discharge (including the MS11mkC
variant) expressed paraglobosyl structures (Schneider et al.,1991;
John et al., 1999). Gonococci isolated from symptomatic men
with naturally acquired gonorrhea also widely express ganglio-
syl or paraglobosyl LOS, but rarely express the lactosyl moiety
(Schneider et al., 1991). In the MS11 background, expression of
paraglobosyl LOS increased the apparent infectivity of the mkC
variantcomparedtothemkAvariant(5/5vs.2/5inoculatedvolun-
teers infected with 4×104 cfu, Schneider et al., 1995), suggesting
that this structure is important in the pathogenesis of gonococcal
urethritis. However, N. gonorrhoeae strain FA1090, which is less
infectious than MS11mkC in the human model, also expresses a
paraglogosylLOS.Thus,therelativeinfectivityof thetwodifferent
strains cannot be attributed to expression of this structure.
Taken together, the observations described above suggest that
gonococci producing gangliosyl or paraglobosyl LOS species are
at a selective advantage during infection of the male urethra. To
directlytestthisidea,Shaferandcolleaguesareconstructingavari-
antofN.gonorrhoeae FA1090thatshouldnotexpressgangliosylor
paraglobosylLOSduetoaninternaldeletionthatremovesmostof
lgtA and lgtC and all of lgtB. This mutant should only express the
3.6-kD lactosyl LOS structure. Competitive experimental infec-
tions with inocula containing this non-variable LOS mutant and
wild-typestrainFA1090,whichcanfreelyphasevaryitsLOSstruc-
tures,coulddeterminewhetherphase-variableproductionof LOS
structures is important during infection. If the ability to alter LOS
structures during urethral infection is advantageous, the“locked-
in” mutant is predicted to have a ﬁtness defect or disadvantage
in vivo.
The lipid A core of gonococcal LOS has endotoxic activity,and
recent evidence indicates that PEA modiﬁcation at the 4  position
is an important determinant in the capacity of strains to resist
complement-mediated killing by normal human serum (Lewis
et al., 2009; Balthazar et al., 2011). The presence of PEA can also
enhance resistance to cationic antimicrobial peptides. Interest-
ingly, PEA modiﬁcation at heptose II does not impart such resis-
tance. Shafer and co-workers have constructed an lptA deletion
mutant of N. gonorrhoeae strain FA1090 (W. M. Shafer, unpub-
lished data). Mixed experimental infections with this mutant,
whichcannotmodifylipidAwithPEA,andwild-typeFA1090will
test whether PEA-containing lipid A provides a ﬁtness advantage
to gonococci during urethral infection.
The terminal paraglobosyl oligosaccharide recognized by Mab
3F11 and expressed by MS11mkC and FA1090 variants used in
experimental infection studies to date can be modiﬁed by gono-
coccal sialyltransferase, resulting in the addition of host-derived
sialic acid to the bacterial surface, mimicking human cell surface
antigens (Mandrell et al., 1988, 1990; Apicella et al., 1990; Par-
sons et al., 1994). Sialylation of gonococcal LOS in vitro increases
serum resistance of intrinsically serum sensitive strains (Grifﬁss
et al., 1991), promotes gonococcal resistance to killing by human
neutrophils (Kim et al., 1992; Rest and Frangipane, 1992; Wetzler
et al.,1992;Gill et al.,1996),and protects N. gonorrhoeae from the
bactericidalactivityof porinandLOS-speciﬁcantibodies(Parsons
etal.,1989;Elkinsetal.,1992;Wetzleretal.,1992;Gilletal.,1996).
Furthermore,immunoelectron microscopic analysis of gonococci
inurethralsecretionsfrommenwithnaturallyacquiredgonorrhea
indicates that sialylation occurs during infection (Apicella et al.,
1990). However, sialylation of MS11mkC prior to urethral inoc-
ulation appears to reduce infectivity of this strain and lengthen
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the incubation period for development of symptomatic urethritis
(Schneider et al., 1996). Sialylation also reduces gonococcal inva-
sion of primary urethral epithelial cells in vitro (Harvey et al.,
2001). These observations suggest that gonococcal sialylation in
the male urethra may occur after the initial stages of infection.
The presence or absence of sialylation of LOS may also be impor-
tant for bacterial survival during different phases of infection or
in different compartments during infection. For example, non-
sialylatedgonococcimaymoreeasilyenterurethralepithelialcells,
whereassialylationmaybeprovideprotectionfromthebactericidal
effectsoftransudatedserumthatcouldaffectextracellularbacteria
on the urethral mucosa. N. gonorrhoeae likely alternates between
intracellularandextracellularcompartmentsduringinfection,and
variable LOS sialylation may facilitate transitions between these
compartments.
Sialyltransferase (lst) mutants of N. gonorrhoeae MS11mkC
and FA1090 have been tested in the experimental human model,
and lst-deﬁcient gonococci from both backgrounds are able to
cause infection in the male urethra (J. G. Cannon, unpublished
data).Afterinoculationwithanlst nullmutantintheserumresis-
tant FA1090 background at an approximate ID80 for wild-type
FA1090, three out of four subjects became infected. FA1090lst
gonococci were recovered from the urine of all three infected sub-
jects; two developed urethral discharge during the 5-days after
inoculation, and the third remained asymptomatic during the
experimental trial. In the relatively serum sensitive MS11mkC
background at an approximate ID80 for the wild-type strain,
four out of eight subjects became infected after inoculation
with an lst null mutant. MS11mkClst g o n o c o c c iw e r er e c o v -
ered from the urine of all four infected subjects; two developed
urethral discharge during the 5-days after inoculation, and the
other two infected subjects remained asymptomatic during the
experimental trial.
Because asymptomatic experimental infection with wild-type
MS11mkC is rare, the lack of sialyltransferase activity may have
altered the pathogenesis of this strain in experimental urethral
infection. However, experimental human infection trials with
small numbers of subjects receiving individual inocula containing
only mutant or wild-type gonococci often does not provide suf-
ﬁcient power to demonstrate reduced infectivity or pathogenesis
with statistical conﬁdence. In experimental infection of female
mice inoculated with wild-type MS11 or an isogenic lst mutant,
WuandJersesawnosigniﬁcantdifferenceininfectivity,consistent
with the results of experimental human infection. Using more
sensitive competitive infections in mice inoculated with mixtures
of wild-type gonococci and similar numbers of the lst mutant,
bacteria lacking lst were signiﬁcantly attenuated in the capacity
to colonize the lower female murine genital tract (Wu and Jerse,
2006).Competitiveinfectionswithmixedinoculainexperimental
human infection may reveal an advantage for expression of sialyl-
transferase in MS11 and/or FA1090 in the male urethra that was
not apparent in previous infections with pure inocula.
The effects of differences in LOS expression on experimental
N. gonorrhoeae infection of male volunteers are summarized in
Table 2.
OPACITY (OPA) PROTEIN EXPRESSION DURING EXPERIMENTAL
URETHRAL INFECTION
Individual N. gonorrhoeae strains possess 11 or 12 opa genes,each
of whichissubjecttoreversible,highfrequencychangesinexpres-
sion state. As a result, individual gonococci can express one or
multiple different Opa proteins,or none at all. Sequence diversity
in regions of opa genes encoding antigenic determinants exposed
on the bacterial surface confers speciﬁcities for different receptors
onhumancells.MostOpavariantsbindtohumancarcinoembry-
onic antigen cell adhesion molecule (CEACAM) family receptors,
howeverasmallnumberof Opaproteinsbindheparinsulfatepro-
teoglycans (HSPGs). Opa-mediated interactions between gono-
cocci and host cells can activate neutrophils or suppress activation
and proliferation of CD4+ T lymphocytes, depending on which
receptors are engaged (reviewed in Sadarangani et al., 2011). Opa
protein repertoires of different N. gonorrhoeae strains differ in
primary amino acid sequences, and the nomenclature in the lit-
erature describing individual Opa proteins in different strains is
ambiguous.Theopa genesof strainsFA1090andMS11showlittle
homology in the variable regions encoding antigenic portions of
the proteins (Connell et al., 1990; Bhat et al., 1991), and proteins
referredtoasOpaA,OpaB,etc.,arenotthesameinthetwostrains.
Early observations by James and Swanson (1978) documented
that gonococci isolated from men with urethritis predominantly
formedthecharacteristicallyopaquecoloniesassociatedwithOpa
protein expression. There is also strong selection for expression
of Opa proteins in the male urethra following inoculation with
wild-typevariantsofFA1090orMS11mkCthatarepredominantly
Table 2 | Effects of lipoologosaccharide (LOS) features on experimental gonorrhea.
Phenotype tested Strain background Experimental outcome References
Natural phase variation
resulting in changes in LOS
structures
MS11mkC Expression of paraglobosyl structures
favored during infection
Schneider et al. (1995)
Ability to sialylate paraglobosyl
LOS structures
FA1090 (serum resistant) Sialyltransferase (lst) mutant as
infectious as wild-type with pure inocula
J. G. Cannon (unpublished data)
MS11mkC (serum
sensitive)
Trend toward lower infectivity for lst
mutant compared to wild-type with pure
inocula
J. G. Cannon, (unpublished data)
LOS, lipooligosaccharide; lst, gene encoding gonococcal sialyltransferase.
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Opa-negative (Jerse et al., 1994; Schmidt et al., 2000). Schneider
and colleagues showed that transition from Opa-negative to Opa-
positive MS11mkC gonococci shed by experimentally infected
men is associated with the onset of symptoms (Schneider et al.,
1995, 1996; Schmidt et al., 2000). Using strain FA1090, J e r s ee ta l .
(1994) showed that not only are Opa+ variants uniformly iso-
lated from urine and urethral swab cultures from experimentally
infected men, the proportion of isolates expressing multiple Opa
proteins increases over time. No single Opa protein in either
strain’s repertoire is selectively expressed during experimental
infection; different Opas predominated among colonies isolated
from individual subjects. However,there are Opa proteins in each
strain’s repertoire that appear to be under-represented among
isolates from experimentally infected subjects (Jerse et al., 1994;
Schmidt et al., 2000).
Following inoculation with predominantly Opa-negative
N. gonorrhoeae FA1090, variants expressing this strain’s OpaA
alone were not isolated from any of the subjects, and only a small
number of reisolates expressed OpaA in conjunction with one
or more other Opa proteins (Jerse et al., 1994). Opa-expressing
FA1090 have also been used to initiate experimental urethral
infections. Inoculation with 104 cfu of FA1090 expressing pre-
dominantly OpaA (along with the 3F11 LOS epitope and 98.8%
identicalpilinaminoacidsequencecomparedtotheOpa-negative
inoculum variant) resulted in infection in four out of ﬁve sub-
jects, and three of the four infected subjects developed acute
urethritis within 1–3days after inoculation. The fourth subject
shed gonococci in his urine, but remained asymptomatic during
the 4-day trial. Gonococci isolated at the onset of signs of acute
urethritis resulting from the predominantly OpaA inoculum con-
tinued to express OpaA, but in conjunction with one or more
other Opa proteins. Gonococci expressing multiple Opa proteins
represented a markedly higher proportion of isolates recovered
from subjects inoculated with FA1090 OpaA (mean 96.7%, range
92–100%; n =3 subjects) than was observed with predominantly
Opa-negative inocula (mean 47.8%; range 18–100%; n =9 sub-
jects) or with an FA1090 variant expressing predominantly OpaF
(mean28.3%;range7–75%;n =3subjects;J.G.CannonandA.E.
Jerse, unpublished data). In contrast to FA1090 OpaA, the OpaF
protein was highly represented among reisolates from subjects
inoculated with Opa-negative FA1090 (Jerse et al., 1994). Thus,
gonococciexpressingOpaAaloneappearedtobeatadisadvantage
during experimental urethral infection.
Rest and colleagues demonstrated that, in contrast to other
Opa variants of FA1090,OpaA variants are resistant to neutrophil
killing in vitro (Fischer and Rest, 1988; Elkins and Rest, 1990).
Therelevanceof invitro Opa-mediatedstimulationof neutrophils
to urethral pathogenesis is not clear. One might predict that
resistance to neutrophil killing would provide an advantage for
OpaA expression during infection. However, the rarity of OpaA
expression following inoculation with Opa-negative gonococci,
and the additional expression of other Opa proteins following
inoculation with OpaA expressers confound this hypothesis, as
presumably multiple expressers would be killed by neutrophils.
These results suggest that FA1090 OpaA may not mediate
key function(s) required for gonococcal survival in the male
urethra.
The rapid and uniform shift from Opa-negative to Opa pro-
teinexpressionbygonococciinthemaleurethraexhibitedbyboth
wild-typestrainsFA1090andMS11mkCsuggestedthatthecapac-
ity to express opacity proteins may be required during urethral
infection, and an Opa-deﬁcient FA1090 mutant was predicted to
be attenuated in the human experimental model. FA1090opaA-
K is a genetically deﬁned mutant in which all 11 opa genes of
this strain have been inactivated (Cole et al., 2010). Inoculation
with FA1090opaA-K at doses ranging from 5.5 to 6.4 Log10 cfu
resulted in infection in four out of eight subjects (J. G. Can-
non,unpublisheddata).FA1090opaA-K gonococciwererecovered
from the urine of all four infected subjects; three of the four
developed urethral discharge within 4days after inoculation, the
fourth remained asymptomatic during the 5-day experimental
trial. Thus,Opa protein expression is not required for gonococcal
infection in the male urethra.
Opa protein expression does confer an advantage in the late
stages of female murine genital tract using FA1090opaA-K and
a complemented strain that constitutively expresses OpaB, with
statistically signiﬁcant differences in colonization load observed
on days 9–14 of infection (Cole et al., 2010). Whether a sim-
ilar advantage for Opa expression could be demonstrated in
the human male urethra is not clear. Experimental infection in
men is limited to earlier stages of infection than can be studied
using the murine model; an advantage for Opa protein expres-
sion that did not manifest until later stages of urethral infection
could not be observed in the human model. The murine and
humangenitaltractsdifferinexpressionof receptorsforOpapro-
teins, and the selective pressures inﬂuencing Opa protein expres-
sion in the male and female human genital tracts likely differ.
Thus, the apparent advantage conferred by Opa expression in the
female murine genital tract may not apply to urethral infection
in men.
PILIN EXPRESSION AND VARIATION IN VIVO
Gonococcal type 4 pili are important for attachment to host
cells, and phase and antigenic variation of PilE, the major pilin
protein, are thought to provide the gonococcus with mechanisms
of immune evasion and tissue tropism (reviewed in Virji, 2009).
Gonococci recovered from men and women with symptomatic,
naturallyacquiredgonorrheaareuniformlypiliated(Kelloggetal.,
1963, 1968). Early experimental infections of male volunteers
(with N. gonorrhoeae strain F62) showed that piliated gonococci
were infectious and produced purulent urethral exudates, and
virulence was retained after extensive selective passage in vitro
(Kellogg et al., 1963). In contrast, though non-piliated inocula
were infectious, infected men developed a watery urethral dis-
charge or none at all (Kellogg et al., 1968). Furthermore, after
extensive passage in vitro, non-piliated F62 gonococci were non-
infectious (Kellogg et al., 1963). Regardless of whether piliated
or non-piliated inocula were used, gonococci recovered from
infected subjects were uniformly piliated (Kellogg et al., 1963,
1968).
Rapidandextensiveantigenicvariationof PilEhasbeenshown
to occur during experimental urethral infection with N. gonor-
rhoeae FA1090 (Seifert et al., 1994; Wright et al., 1994; Ham-
rick et al., 2001) and MS11mk (Swanson et al., 1987). These
Frontiers in Microbiology | Cellular and Infection Microbiology May 2011 | Volume 2 | Article 123 | 6Hobbs et al. Experimental human gonorrhea
observations suggested that type 4 pilus expression may be
required for urethral gonococcal infection, and a non-reverting,
non-piliated FA1090 mutant was predicted to be non-infectious
inthehumanexperimentalmodel.Thepromoterand5  endofthe
single pilin expression locus was deleted in FA1090pilE (Cannon
et al., 1996). Inoculation with approximately 106 cfu (∼ID80 for
piliated wild-type FA1090) of Opa-negative FA1090pilE express-
ingtheparaglobosylLOSepitoperecognizedbyMab3F11resulted
in infection in six out of eight subjects (J. G. Cannon, unpub-
lished data). Non-piliated gonococci were cultured from urine
from all infected subjects. Three of the six subjects infected with
the pilE mutant developed a watery urethral discharge, and the
remainingsubjectsremainedasymptomaticthroughoutthe5-day
experimental trial, consistent with Kellogg et al. (1963, 1968) ear-
lier observations with phase-variable, non-piliated inocula that
switched to pilus expression during infection. These results sug-
gest that host responses to piliated and non-piliated gonococci
may differ during early stages of urethral infection. The fact
that pilus expression is not required for infection in men sug-
gests there may be a role for alternative adhesins in urethral
colonization.
Although FA1090pilE does not elaborate a pilus ﬁber, this
mutant does express the pilus-associated PilC protein, which can
be present both in pilus ﬁbers and in the gonococcal outer mem-
brane (Rudel et al., 1995; Rahman et al., 1997). PilC is important
for adherence of piliated gonococci to human epithelial cells
(Rudel et al., 1992; Nassif et al., 1994; Kirchner and Meyer, 2005),
and in the absence of PilE, PilC has also been shown to increase
adherenceof FA1090toepithelialcellsinvitro,thoughtheeffectof
PilC expression on non-piliated gonococci is modest compared to
adherence of piliated bacteria (C. E. Thomas, unpublished data).
Mixed experimental infections with FA1090pilE expressing PilC
and a mutant that expresses neither PilE nor PilC may help eluci-
date the roles of these two proteins in gonococcal pathogenesis in
the male urethra.
The effects of opacity protein and pilin expression on experi-
mental N. gonorrhoeae infection of male volunteers are summa-
rized in Table 3.
IgA PROTEASE IS NOT REQUIRED DURING EXPERIMENTAL
GONOCOCCAL URETHRITIS
IgA1 protease production is associated with mucosal pathogens
including N. gonorrhoeae, N. meningitidis, and Haemophilus
inﬂuenzae (Kilian et al., 1996). In addition to its ability to cleave
IgA1 at mucosal surfaces, gonococcal IgA1 protease also cleaves
the lysosome-associated membrane protein 1 (Lamp1) promot-
ing intracellular bacterial survival in epithelial cells in vitro (Lin
et al., 1997; Ayala et al., 2002). These observations suggested that
the enzyme may contribute to gonococcal pathogenesis. Cannon
and colleagues showed that a N. gonorrhoeae FA1090 iga mutant
(Opa−,P +, and expressing the 3F11 LOS epitope) that lacks
IgA1 protease activity is fully capable of causing urethritis in male
volunteers (Johannsen et al., 1999).
IgA1 protease could be more important in later stages of infec-
tion than can be assessed in the human model of uncomplicated
urethritis in naïve volunteers. Protease function could contribute
to later-stage invasive complications,or may play a role in reinfec-
tionof previouslyexposedindividualsbyinactivatingpre-existing
mucosal antibodies (Johannsen et al., 1999). The role of IgA1
protease in gonococcal infection in women has not been tested.
IMPORTANCE OF TRANSFERRIN AND LACTOFERRIN
RECEPTORS IN GONOCOCCAL PATHOGENESIS
Like all N. gonorrhoeae strains, FA1090, and MS11mkC can use
iron from human transferrin (Tf) for growth. One of the notable
differences between these two strains (Table 1) is their differen-
tial ability to obtain iron from human lactoferrin (Lf). MS11mkC
expresses lactoferrin-binding protein A (LbpA) and is phenotypi-
cally Tf+Lf+, whereas FA1090 has a naturally occurring deletion
that eliminates expression of LbpA and is unable to grow on
lactoferrin as a sole source of iron (Anderson et al., 2003). Thus,
wild-type FA1090,like approximately half of clinical isolates of N.
gonorrhoeae that have been examined (Mickelsen et al., 1982; Fox
etal.,1998;Andersonetal.,2001),isphenotypicallyTf+Lf−.Cor-
nelissenetal.(1998)showedthatatransferrin-receptormutantof
FA1090,whichcannotobtainironfromeitherTforLf,isincapable
ofcausingurethritisintheexperimentalhumangonorrheamodel.
Table 3 | Effects of opacity protein (Opa) and pilin (PilE) expression on experimental gonorrhea.
Phenotype tested Strain background Experimental outcome References
Natural phase variation
resulting in changes in Opa
expression
MS11mkC and FA1090 Opa expression favored during infection
after inoculation with Opa-negative
variant
Jerse et al. (1994), Schmidt et al.
(2000)
Requirement for Opa
expression
FA1090 Mutant unable to express Opa proteins
as infectious as wild-type
J. G. Cannon (unpublished data)
Natural antigenic variation in
PilE protein
MS11mkC and FA1090 Extensive variation observed during
infection with piliated variant
Seifert et al. (1994),Wright et al.
(1994), Hamrick et al. (2001),
Swanson et al. (1987)
Requirement for PilE
expression
FA1090 Non-piliated mutant unable to express
PilE as infectious as wild-type
J. G. Cannon (unpublished data)
Opa, opacity protein; PilE, pilin protein.
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Sparling and colleagues showed that a N. gonorrhoeae FA1090
engineered mutant capable of using Lf but not Tf, a combina-
tion not seen in nature, causes experimental urethral infection in
male volunteers that is similar to infections caused by wild-type
FA1090 (Anderson et al., 2003). Thus iron from either Tf or Lf
enables gonococcal growth and pathogenesis in the male urethra.
To determine whether the ability to use human Lf provides
an advantage to gonococci that also can use human Tf, Sparling
and colleagues conducted competitive infections with wild-type
FA1090 (Tf+Lf−)a n daT f +Lf+ mutant. Inoculation with an
approximate ID50 for wild-type FA1090 containing a mixture of
equivalent numbers of both strains resulted in infection in nearly
half of subjects. In each of ﬁve infected subjects, the Tf+Lf+
strain exhibited a signiﬁcant competitive advantage over wild-
type FA1090; urine and urethral swab cultures from all subjects
contained 100% mutant gonococci at the end of the experimen-
tal trial (Anderson et al., 2003). Thus, the experimental model
using a competitive infection study design has the potential to
demonstratedifferencesinﬁtnessbetweengonococcalstrainswith
statistical conﬁdence, even when the overall infectivity of the two
strains is not demonstrably different.
The requirements for IgA protease and iron acquisition from
humaniron-bindingproteinsduringexperimentalN.gonorrhoeae
infection of male volunteers are summarized in Table 4.
POPULATION DYNAMICS IN EXPERIMENTAL INFECTION
Trackingthevariationof opacityandpilinproteinsduringexperi-
mental infection with wild-type N. gonorrhoeae reveals that the
phenotype of infecting bacteria changes multiple times in the
intervalbetweeninoculationandthedevelopmentof urethraldis-
charge (Jerse et al., 1994; Seifert et al., 1994; Wright et al., 1994;
Schmidt et al., 2000; Hamrick et al., 2001). As shown schemat-
ically in Figure 2, inoculum variants disappear rapidly and are
replaced by a series of new variants expressing different combi-
nations of surface antigens. The gonococcal population becomes
more complex as infection proceeds, consisting of a mixture of
multiple variants at the time a urethral discharge is present. These
changes are consistent with sequential outgrowth and disappear-
ance of clonal populations expressing combinations of Opa and
FIGURE2|P opulation dynamics during experimental gonococcal
infections.The schematic representation depicts an inoculating population
that is predominantly composed of one combination of variable traits,
represented by red in the ﬁrst pie chart and the red trace in the graph
below. Following the eclipse period during which few gonococci are
recovered, new variants, indicated by different colors, emerge.The
population of infecting gonococci becomes increasingly complex over time.
The colors represent different phenotypic variants that could arise by phase
and/or antigenic variation of opacity and pilin proteins and are based on
previously reported observations (Jerse et al., 1994; Seifert et al., 1994;
Wright et al., 1994; Hamrick et al., 2001) but are not intended to represent
speciﬁc characteristics of actual reisolates from an experimental infection.
PilEandpossiblyothertraits.Theeclipseperiodthatoccursimme-
diately after inoculation could result in a population bottleneck,
with the subsequent gonococcal population expanding from one
or a few organisms present in the inoculum. New variants gen-
erated through phase and antigenic variation may descend from
a single organism; these new variants proliferate if they express
advantageous combinations of traits and eventually replace the
previous population.
The selective pressures that could result in the sequential out-
growth and disappearance of gonococcal variants are not known.
However, the possibility that very few bacteria emerge from a
Table 4 | Requirements for IgA protease and iron acquisition from human iron-binding proteins during experimental gonorrhea.
Phenotype tested Strain background Experimental outcome References
Requirement for IgA protease activity FA1090 Mutant unable to express IgA protease
as infectious as wild-type
Johannsen et al. (1999)
Requirement for lactoferrin (Lf)
utilization in the absence of transferrin
(Tf) utilization
FA1090 Mutant unable to use either Lf orTf is
non-infectious
Cornelissen et al. (1998)
Ability to use Lf in the absence ofTf
utilization
FA1090 Mutant able to use Lf only as infectious
as wild-type that usesTf only
Anderson et al. (2003)
Ability to use both Lf andTf FA1090 Mutant able to use both Lf andTf
showed competitive advantage over
wild-type in mixed infections
Anderson et al. (2003)
IgA, immunoglobulin A; Lf, lactoferrin;Tf, transferrin.
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selectivebottlenecktoinitiateinfectionfollowingtheinitialeclipse
periodcouldconfoundinterpretationofresultsfrommixedexper-
imentalinfectionswithisogenicstrainsdifferinginexpressionof a
postulatedvirulencefactor.Figure3Ashowstheoreticaloutcomes
of mixed infection initiated under conditions with and without
the hypothetical bottleneck. In the absence of a dramatic popula-
tion restriction, gonococcal populations reisolated from infected
subjects would be expected to contain mixtures of the two strains
in similar proportions to their representation in the inoculum, if
they have equal ﬁtness during infection (Pattern A). If one strain
hasacompetitiveadvantage,thisstrainwouldeventuallypredom-
inate among reisolated bacteria (Pattern B). If the bottleneck does
reduce the infecting gonococcal population to very few bacteria,
and one strain has a competitive advantage, that strain would be
expected to predominate early among reisolates and be recovered
exclusively from all infected subjects (Pattern C). If both input
strains have equivalent ﬁtness,each would be equally likely to sur-
vivethebottleneck,andeachshouldpredominateamongreisolates
from roughly half of infected subjects (Pattern D).
Figure 3B shows the actual results of mixed infections with
wild-type Tf+Lf− and mutant Tf+Lf+ N. gonorrhoeae FA1090
strains.Perhapsnotsurprisingly,thedatadonotﬁtclearlyintoone
single predicted outcome pattern. From over half of the infected
subjects (3/5), only Tf+Lf+ gonococci were recovered following
a noticeable eclipse. From the other two subjects, Tf+Lf+ gono-
cocci eventually overtook the population after mixtures of both
inoculating strains were recovered. The persistence of substantial
numbersofbothinputstrainswithgradualoutcompetitionbythe
Tf+Lf+straininsomesubjectssuggeststhatthereisnotauniver-
sal bottleneck limiting the establishment of experimental urethral
infectiontooneorafewgonococciintheinfectingpopulation.The
fact that cultures from all infected subjects ultimately contained
100% Tf+Lf+ gonococci suggests that this strain had a selective
advantage over the Tf+Lf− wild-type strain during experimental
infection of the male urethra. However, the population dynamics
appeared to be different in different subjects. It is possible that
there are individual differences in the effectiveness of innate host
defenses, and these could affect the number of organisms in
the original inoculum that survive and replicate to generate the
infecting population.
Interpretation of mixed experimental infections could be fur-
ther confounded by the potential for in vivo transformation
betweenco-infectinggonococcalcells.In vitro modelssuggestthat
transformation during infection is possible, and the formation of
mosaicgenesisindirectevidencethatitoccursinthehumanhost.
Gonococcalisolatesthathavebeenrecoveredtodatefromsubjects
inoculatedwithmixturesofisogenicstrainsshowednoevidenceof
transformation during the relatively short experimental infection
period (Anderson et al., 2003). However, only genetic exchanges
that resulted in mosaic structures involving the engineered gene
wouldhavebeendetected.Recentimprovementsinwholegenome
sequencing technologies may enable a more comprehensive and
sensitiveapproachtoexplorewhetherhorizontalgeneticexchange
occurs during experimental urethral infection.
SAFETY AND UTILITY OF THE EXPERIMENTAL HUMAN
GONORRHEA MODEL
Experimental infection of male volunteers with N. gonorrhoeae is
safe, and subjects infected with wild-type gonococci exhibit the
signs and symptoms of natural infection. The risks of serious
complications from urethral gonococcal infection are extremely
rare, even in natural infection. Hundreds of subjects have par-
ticipated in experimental infection trials without severe adverse
events. Using a competitive infection design with mixed inocula,
the model can discriminate among gonococcal strains with dif-
ferent degrees of ﬁtness for urethral colonization and infection.
Experience with the FA1090 transferrin-receptor mutant showed
thatitispossibletorenderN.gonorrhoeae non-infectiousbyinac-
tivation of a single virulence factor (in a strain that does not
expressthelactoferrinreceptor).Thustheurethralinfectionmodel
FIGURE3|P o t ential inﬂuence of population dynamics on outcomes
of mixed experimental infections. In (A), theoretical outcomes are
shown for infections initiated by a 50:50 mixture of two isogenic strains
differing in expression of a predicted virulence factor, depicted
as black and white, under conditions with (bottom) and without (top) a
population-restricting bottleneck early after inoculation. Potential
outcomes consistent with and without a competitive advantage for the
black strain are indicated as four patterns of pie charts representing
populations of gonococci recovered from infected subjects. In (B), actual
outcomes are shown for infections initiated by a 45:55 mixture of isogenic
Tf+Lf− (white) andTf+Lf+ (black) strains of N. gonorrhoeae FA1090
(Anderson et al., 2003). In patterns 1–3, each pie chart represents the mixture
of gonococcal strains recovered from infected subjects over the 1- to 5-day
period after inoculation.The   symbol indicates no gonococci were recovered
at early times (1–3days in different volunteers) after inoculation of four
subjects.
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is well-suited to provide insights into the mechanisms of patho-
genesis of N. gonorrhoeae and eventually may prove useful as a
component in the clinical development plan for the evaluation of
a gonococcal vaccine.
ACKNOWLEDGMENTS
WearegratefultoJanneG.Cannonforsharingpreviouslyunpub-
lished data and for critically reviewing the manuscript. We thank
ChristopherE.Thomasforsharingdatainadvanceof publication.
Experimental gonococcal infection studies at the University of
North Carolina at Chapel Hill were supported by the Sexually
Transmitted Infections Cooperative Research Center of the US
National Institutes of Health (U19-AI031496). William M. Shafer
wassupportedinpartbyaSeniorResearchCareerScientistAward
from the Medical Research Service of the Department of Veterans
Affairs.
REFERENCES
Anderson, J. E., Hobbs, M. M., Biswas,
G. D., and Sparling, P. F. (2003).
Opposingselectiveforcesforexpres-
sion of the gonococcal lactofer-
rin receptor. Mol. Microbiol. 48,
1325–1337.
Anderson, J. E., Leone, P. A., Miller, W.
C., Chen, C., Hobbs, M. M., and
Sparling, P. F. (2001). Selection for
expression of the gonococcal hemo-
globin receptor during menses. J.
Infect. Dis. 184, 1621–1623.
Apicella, M. A., Mandrell, R. E., Shero,
M., Wilson, M. E., Grifﬁss, J. M.,
Brooks, G. F., Lammel, C., Breen, J.
F., and Rice, P. A. (1990). Modiﬁca-
tion by sialic acid of Neisseria gonor-
rhoeae lipooligosaccharide epitope
expression in human urethral exu-
dates: an immunoelectron micro-
scopic analysis. J. Infect. Dis. 162,
506–512.
Ayala, P., Vasquez, B., Wetzler, L.,
and So, M. (2002). Neisseria
gonorrhoeae porin P1.B induces
endosome exocytosis and a redis-
tribution of Lamp1 to the plasma
membrane. Infect. Immun. 70,
5965–5971.
Balthazar, J. T., Gusa, A., Martin, L.
E., Chouhury, B., Carlson, R., and
Shafer, W. M. (2011). Lipooligosac-
charide structure is an impor-
tant determinant in the resis-
tance of Neisseria gonorrhoeae to
antimicrobial agents of innate host
defense. Front. Microbiol. 2:30. doi:
10.3389/fmicb.2011.00030
Banerjee,A.,Wang,R.,Uljon,S.N.,Rice,
P. A., Gotschlich, E. C., and Stein, D.
C. (1998). Identiﬁcation of the gene
(lgtG)encodingthelipooligosaccha-
ride beta chain synthesizing gluco-
syl transferase from Neisseria gonor-
rhoeae. Proc. Natl. Acad. Sci. U.S.A.
95, 10872–10877.
Bhat, K. S., Gibbs, C. P., Barrera, O.,
Morrison, S. G., Jahnig, F., Stern,
A., Kupsch, E. M., Meyer, T. F., and
Swanson,J.(1991).Theopacitypro-
teins of Neisseria gonorrhoeae strain
MS11 are encoded by a family of
11 complete genes. Mol. Microbiol.
5, 1889–1901.
Cannon, J. G., Cohen, M. S., Isbey,
S. F., Snodgrass, T. L., Wallace, A.,
Dempsey, J. A. F., Apicella, M.,
and Zhou, D. (1996). “Infectivity of
gonococcal mutants in the human
challenge model,” in 10th Interna-
tional Pathogenic Neisseria Confer-
ence, Baltimore, MD.
Cohen,M. S.,and Cannon,J. G. (1999).
Human experimentation with Neis-
seria gonorrhoeae: progress and
goals. J. Infect. Dis.179, S375–S379.
Cohen, M. S., Cannon, J. G., Jerse, A.
E., Charniga, L. M., Isbey, S. F.,
and Whicker, L. G. (1994). Human
experimentation with Neisseria gon-
orrhoeae: rationale, methods, and
implicationsforthebiologyofinfec-
tion and vaccine development. J.
Infect. Dis. 169, 532–537.
Cole, J. G., Fulcher, N. B., and Jerse, A.
E. (2010). Opacity proteins increase
Neisseria gonorrhoeae ﬁtness in the
female genital tract due to a fac-
tor under ovarian control. Infect.
Immun. 78, 1629–1641.
Connell, T. D., Shaffer, D., and Can-
non, J. G. (1990). Characterization
of the repertoire of hypervariable
regions in the Protein II (opa)g e n e
familyof Neisseriagonorrhoeae.Mol.
Microbiol. 4, 439–449.
Cornelissen, C. N., Kelley, M., Hobbs,
M. M., Anderson, J. E., Cannon,
J. G., Cohen, M. S., and Sparling,
P. F. (1998). The transferrin recep-
tor expressed by gonococcal strain
FA1090 is required for the experi-
mentalinfectionofhumanmalevol-
unteers.Mol.Microbiol.27,611–616.
Dillard, J. P., and Seifert, H. S. (2001).
A variable genetic island speciﬁc for
Neisseria gonorrhoeae is involved in
providingDNAfornaturaltransfor-
mation and is found more often in
disseminated infection isolates. Mol.
Microbiol. 41, 263–277.
Edwards, J. L., and Apicella, M. A.
(2004). The molecular mechanisms
usedbyNeisseriagonorrhoeae to ini-
tiate infection differ between men
andwomen.Clin.Microbiol.Rev. 17,
965–981.
Edwards,M.,McDade,R. L.,Schoolnik,
G., Rothbard, J. B., and Gotschlich,
E. C. (1984). Antigenic analysis
of gonococcal pili using mono-
clonal antibodies. J. Exp. Med. 160,
1782–1791.
Elkins, C., Carbonetti, N. H., Varela,
V. A., Stirewalt, D., Klapper, D. G.,
and Sparling, P. F. (1992). Anti-
bodies to N-terminal peptides of
gonococcal porin are bactericidal
whengonococcallipopolysaccharide
is not sialylated. Mol. Microbiol. 6,
2617–2628.
Elkins, C., and Rest, R. F. (1990). Mon-
oclonal antibodies to outer mem-
brane protein PII block interac-
tions of Neisseria gonorrhoeae with
human neutrophils. Infect. Immun.
58, 1078–1084.
Fischer, S. H., and Rest, R. F. (1988).
Gonococci possessing only cer-
tain P. II outer membrane
proteins interact with human
neutrophils. Infect. Immun. 56,
1574–1579.
Fox, K. K., Thomas, J. C., Weiner,
D. H., Davis, R. H., Sparling,
P. F., and Cohen, M. S. (1998).
Longitudinal evaluation of serovar-
speciﬁc immunity to Neisseria gon-
orrhoeae. Am. J. Epidemiol. 149,
353–358.
Frieden, T. R., and Collins, F. S. (2010).
Intentional infection of vulnerable
populations in 1946–1948: another
tragic history lesson. JAMA 304,
2063–2064.
Gill, M. J., McQuillen, D. P., van
Putten, J. P., Wetzler, L. M.,
Bramley, J., Crooke, H., Parsons,
N. J., Cole, J. A., and Smith,
H. (1996). Functional characteriza-
tion of a sialyltransferase-deﬁcient
mutant of Neisseria gonorrhoeae.
Infect. Immun. 64, 3374–3378.
Grifﬁss, J. M., Jarvis, G. A., O’Brien,
J. P., Eads, M. M., and Schnei-
der, H. (1991). Lysis of Neisse-
ria gonorrhoeae initiated by bind-
ing of normal human IgM to a
hexosamine-containing lipooligos-
accharide epitope(s) is augmen-
ted by strain-speciﬁc, properdin-
binding-dependentalternativecom-
plement pathway activation. J.
Immunol. 147, 298–305.
Hamrick, T. S., Dempsey, J. A., Cohen,
M. S., and Cannon, J. G. (2001).
Antigenic variation of gonococcal
pilin expression in vivo: analysis of
the strain FA1090 pilin repertoire
and identiﬁcation of the pilS gene
copies recombining with pilE dur-
ing experimental human infection.
Microbiology 147, 839–849.
Harvey, H. A., Jennings, M. P., Camp-
bell,C.A.,Williams,R.,andApicella,
M. A. (2001). Receptor-mediated
endocytosis of Neisseria gonorrhoeae
intoprimaryhumanurethralepithe-
lial cells: the role of the asialoglyco-
protein receptor. Mol. Microbiol. 42,
659–672.
Hosmer, D. W., and Lemeshow, S.
(2000). Applied Logistic Regression.
Hoboken, NJ: John Wiley & Sons,
Inc.
Hunter,J.(1835).“Atreatiseonvenereal
disease,”inTheWorksofJohnHunter,
Vol. 2, ed. J. F. Palmer (London:
Longman), 417.
James, J. F., and Swanson, J. (1978).
Studies on gonococcus infection.
XIII. Occurrence of color/opacity
colonial variants in clinical cultures.
Infect. Immun. 19, 332–340.
Jerse, A. E. (1999). Experimental
gonococcal genital tract infection
and opacity protein expression
in estradiol-treated mice. Infect.
Immun. 67, 5699–5708.
Jerse,A. E.,Cohen,M. S.,Drown,P. M.,
Whicker,L.G.,Isbey,S.F.,Seifert,H.
S., and Cannon, J. G. (1994). Multi-
ple gonococcal opacity proteins are
expressed during experimental ure-
thral infection in the male. J. Exp.
Med. 179, 911–920.
Johannsen,D. B.,Johnston,D. M.,Koy-
men, H. O., Cohen, M. S., and Can-
non, J. G. (1999). A Neisseria gonor-
rhoeae immunoglobulinA1protease
mutant is infectious in the human
challenge model of urethral infec-
tion. Infect. Immun. 67, 3009–3013.
John, C. M., Schneider, H., and Griff-
iss, J. M. (1999). Neisseria gon-
orrhoeae that infect men have
lipooligosaccharides with terminal
N-acetyllactosamine repeats. J. Biol.
Chem. 274, 1017–1025.
Frontiers in Microbiology | Cellular and Infection Microbiology May 2011 | Volume 2 | Article 123 | 10Hobbs et al. Experimental human gonorrhea
Kellogg, D. S. Jr., Cohen, I. R., Norins,
L. C., Schroeter, A. L., and Reising,
G. (1968). Neisseria gonorrhoeae II.
Colonial variation and pathogenic-
ity during 35 months in vitro. J.
Bacteriol. 96, 596–605.
K ellogg,D .S.Jr .,P eac ock,W .L.Jr .,Dea-
con, W. E., Brown, L., and Pirkle,
C. I. (1963). Neisseria gonorrhoeae.
I. Virulence genetically linked to
clonal variation. J. Bacteriol. 85,
1274–1279.
Kilian, M., Reinholdt, J., Lomholt,
H., Poulsen, K., and Frandsen, E.
V. (1996). Biological signiﬁcance
of IgA1 proteases in bacterial
colonization and pathogenesis:
critical evaluation of experi-
mental evidence. APMIS 104,
321–338.
Kim,J. J.,Zhou,D.,Mandrell,R. E.,and
Grifﬁss,J.M.(1992).Effectofexoge-
nous sialylation of the lipooligosac-
charide of Neisseria gonorrhoeae on
opsonophagocytosis. Infect. Immun.
60, 4439–4442.
Kirchner, M., and Meyer, T. F. (2005).
The PilC adhesin of the Neisseria
type IV pilus-binding speciﬁcities
and new insights into the nature of
thehostcellreceptor.Mol.Microbiol.
56, 945–957.
Lewis, D. A. (2010). The gonococcus
ﬁghts back: is this time a knock out?
Sex. Transm. Infect. 86, 415–421.
Lewis, L. A., Choudhury, B., Balthazar,
J. T., Martin, L. E., Ram, S., Rice,
P. A., Stephens, D. S., Carlson, R.,
and Shafer,W. M. (2009). Phospho-
ethanolamine substitution of lipid
A and resistance of Neisseria gon-
orrhoeae to cationic antimicrobial
peptides and complement-
mediated killing by normal
human serum. Infect. Immun. 77,
1112–1120.
Lin, L., Ayala, P., Larson, J., Mulks,
M., Fukuda, M., Carlsson, S. R.,
Enns, C., and So, M. (1997).
The Neisseria type 2 IgA1 pro-
tease cleaves LAMP1 and pro-
motes survival of bacteria within
epithelial cells. Mol. Microbiol. 24,
1083–1094.
Mandrell, R. E., Grifﬁss, J. M., and
Macher, B. A. (1988). Lipooligosac-
charides (LOS) of Neisseria gon-
orrhoeae and Neisseria meningitidis
have components that are immuno-
chemically similar to precursors
of human blood group antigens.
Carbohydrate sequence speciﬁcity
of the mouse monoclonal anti-
bodies that recognize crossreact-
ing antigens on LOS and human
erythrocytes. J. Exp. Med. 168,
107–126.
Mandrell, R. E., Lesse, A. J., Sugai, J.
V., Shero, M., Grifﬁss, J. M., Cole,
J. A., Parsons, N. J., Smith, H.,
Morse, S. A., and Apicella, M. A.
(1990). In vitro and in vivo mod-
iﬁcation of Neisseria gonorrhoeae
lipooligosaccharide epitope struc-
ture by sialylation. J. Exp. Med. 171,
1649–1664.
Mickelsen, P. A., Blackman, E., and
Sparling, P. F. (1982). Ability
of Neisseria gonorrhoeae, Neisse-
ria meningitidis, and commensal
Neisseria species to obtain iron
from lactoferrin. Infect. Immun. 35,
915–920.
Nachamkin, I., Cannon, J. G., and
Mittler, R. S. (1981). Monoclonal
antibodies against Neisseria gonor-
rhoeae: production of antibodies
directed against a strain-speciﬁc cell
surface antigen. Infect. Immun. 32,
641–648.
Nassif, X., Beretti, J. L., Lowy, J., Sten-
berg, P., O’Gaora, P., Pfeifer, J.,
Normark, S., and So, M. (1994).
Roles of pilin and PilC in adhe-
sion of Neisseria meningitidis to
human epithelial and endothelial
cells. Proc. Natl. Acad. Sci. U.S.A. 91,
3769–3773.
Parsons, N. J., Andrade, J. R., Patel,
P. V., Cole, J. A., and Smith, H.
(1989). Sialylation of lipopolysac-
charide and loss of absorption of
bactericidalantibodyduringconver-
sion of gonococci to serum resis-
tance by cytidine 5’-monophospho-
N-acetyl neuraminic acid. Microb.
Pathog. 7, 63–72.
Parsons,N. J.,Constantinidou,C.,Cole,
J. A., and Smith, H. (1994). Sia-
lylation of lipopolysaccharide by
CMP-NANA in viable gonococci
is enhanced by low Mr material
released from blood cell extracts but
not by some UDP sugars. Microb.
Pathog. 16, 413–421.
Rahman, M., Kallstrom, H., Normark,
S., and Jonsson, A. B. (1997). PilC
of pathogenic Neisseria is associated
with the bacterial cell surface. Mol.
Microbiol. 25, 11–25.
Ram, S., Cullinane, M., Blom, A.
M., Gulati, S., McQuillen, D. P.,
Boden, R., Monks, B. G., O’Connell,
C., Elkins, C., Pangburn, M. K.,
Dahlback, B., and Rice, P. A. (2001).
C4bp binding to porin mediates sta-
bleserumresistanceofNeisseriagon-
orrhoeae. Int. Immunopharmacol. 1,
423–432.
Ramsey, K. H., Schneider, H., Cross,
A. S., Boslego, J. W., Hoover,
D. L., Staley, T. L., Kuschner,
R. A., and Deal, C. D. (1995).
Inﬂammatory cytokines produced
in response to experimental human
gonorrhea. J. Infect. Dis. 172,
186–191.
Rest, R. F., and Frangipane, J. V. (1992).
Growth of Neisseria gonorrhoeae
in CMP-N-acetylneuraminic acid
inhibits nonopsonic (opacity-
associated outer membrane
protein-mediated) interactions
with human neutrophils. Infect.
Immun. 60, 989–997.
Rouquette, C., Harmon, J. B., and
Shafer, W. M. (1999). Induction
of the mtrCDE-encoded efﬂux
pump system of Neisseria gonor-
rhoeae requires MtrA, an AraC-
like protein. Mol. Microbiol. 33,
651–658.
Rudel, T., Scheurerpﬂug, I., and Meyer,
T. F. (1995). Neisseria PilC pro-
tein identiﬁed as type-4 pilus
tip-located adhesin. Nature 373,
357–359.
Rudel, T., van Putten, J. P., Gibbs,
C. P., Haas, R., and Meyer, T. F.
(1992). Interaction of two variable
proteins (PilE and PilC) required
for pilus-mediated adherence of
Neisseria gonorrhoeae to human
epithelial cells. Mol. Microbiol. 6,
3439–3450.
Sadarangani, M., Pollard, A. J., and
Gray-Owen, S. D. (2011). Opa pro-
teins and CEACAMs: pathways of
immuneengagementforpathogenic
Neisseria. FEMS Microbiol. Rev. 35,
498–514.
Schmidt, K. A., Deal, C. D., Kwan,
M., Thattassery, B. S., and Schnei-
der,H.(2000).Neisseriagonorrhoeae
MS11mkC opacity protein expres-
sion in vitro and during human
volunteer infectivity studies. Sex.
Transm. Dis. 27, 278–283.
Schmidt, K. A., Schneider, H., Lind-
strom, J. A., Boslego, J. W., War-
ren, R. A., Van de Verg, L., Deal,
C. D., McClain, J. B., and Grifﬁss,
J. M. (2001). Experimental gono-
coccal urethritis and reinfection
withhomologousgonococciinmale
volunteers. Sex. Transm. Dis. 28,
555–564.
Schneider, H., Cross, A. S., Kuschner,
R. A., Taylor, D. N., Sadoff, J.
C., Boslego, J. W., and Deal, C.
D. (1995). Experimental human
gonococcal urethritis: 250 Neis-
seria gonorrhoeae MS11mkC
are infective. J. Infect. Dis. 172,
180–185.
Schneider, H., Grifﬁss, J. M., Boslego, J.
W.,Hitchcock,P.J.,Zahos,K.M.,and
Apicella,M.A.(1991).Expressionof
paragloboside-like lipooligosaccha-
rides may be a necessary component
of gonococcal pathogenesis
in men. J. Exp. Med. 174,
1601–1605.
Schneider, H., Schmidt, K. A., Skill-
man, D. R., Van de Verg, L., War-
ren, R. L., Wylie, H. J., Sadoff, J. C.,
Deal, C. D., and Cross, A. S. (1996).
Sialylation lessens the infectivity of
Neisseria gonorrhoeae MS11mkC. J.
Infect. Dis. 173, 1422–1427.
Seifert, H. S., Wright, C. J., Jerse, A.
E., Cohen, M. S., and Cannon, J.
G. (1994). Multiple gonococcal pilin
antigenicvariantsareproduceddur-
ing experimental human infections.
J. Clin. Invest. 93, 2744–2749.
Sheu, J. N., Chen, M. C., Cheng, S. L.,
Lee, I. C., Chen, S. M., and Tsay,
G.J.(2007).Urineinterleukin-1beta
in children with acute pyelonephri-
tis and renal scarring. Nephrology
(Carlton) 12, 487–493.
Sheu, J. N., Chen, M. C., Lue, K. H.,
Cheng, S. L., Lee, I. C., Chen, S.
M., and Tsay, G. J. (2006). Serum
and urine levels of interleukin-6
and interleukin-8 in children with
acute pyelonephritis. Cytokine 36,
276–282.
Simms, A. N., and Jerse, A. E. (2005).
“Role of phase and antigenic varia-
tion in Neisseria gonorrhoeae colo-
nization,”in Colonization of Mucosal
Surfaces, eds J. P. Nataro, H. L. T.
Mobley, and J. N. Weiser (Washing-
ton, DC: ASM Press), 326–250.
Swanson, J., Bergstrom, S., Barrera, O.,
Robbins, K., and Corwin, D. (1985).
Pilus- gonococcal variants. Evidence
for multiple forms of piliation con-
trol. J. Exp. Med. 162, 729–744.
Swanson, J., Robbins, K., Barrera, O.,
Corwin, D., Boslego, J., Ciak, J.,
Blake,M.,andKoomey,J.M.(1987).
Gonococcal pilin variants in experi-
mental gonorrhea. J. Exp. Med. 165,
1344–1357.
van Vliet, S. J., Steeghs, L., Bruijns, S.
C., Vaezirad, M. M., Snijders Blok,
C., Arenas Busto, J. A., Deken, M.,
van Putten, J. P., and van Kooyk, Y.
(2009). Variation of Neisseria gon-
orrhoeae lipooligosaccharide directs
dendritic cell-induced T helper
responses.PLoSPathog.5,e1000625.
doi: 10.1371/journal.ppat.1000625
Virji, M. (2009). Pathogenic neisse-
riae: surface modulation, pathogen-
esis and infection control. Nat. Rev.
Microbiol. 7, 274–286.
Warner, D. M., Shafer, W. M., and
Jerse, A. E. (2008). Clinically rele-
vant mutations that cause derepres-
sion of the Neisseria gonorrhoeae
MtrC-MtrD-MtrE efﬂux pump sys-
temconferdifferentlevelsof antimi-
crobialresistanceandinvivoﬁtness.
Mol. Microbiol. 70, 462–478.
www.frontiersin.org May 2011 | Volume 2 | Article 123 | 11Hobbs et al. Experimental human gonorrhea
Wetzler, L. M., Barry, K., Blake,
M. S., and Gotschlich, E. C.
(1992). Gonococcal lipooligosac-
charide sialylation prevents
complement-dependent killing
by immune sera. Infect. Immun. 60,
39–43.
Wright, C., Jerse, A. E., Cohen, M.
S., Cannon, J. G., and Seifert,
H. S. (1994). Nonrepresentative
PCR ampliﬁcation of variable gene
sequences in clinical specimens con-
taining dilute, complex mixtures of
microorganisms. J. Clin. Microbiol.
32, 464–468.
Wu, H., and Jerse, A. E. (2006).
Alpha-2,3-sialyltransferase enhan-
ces Neisseria gonorrhoeae survival
during experimental murine geni-
taltractinfection. Infect. Immun. 74,
4094–4103.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential
conﬂict of interest.
Received: 01 March 2011; paper pend-
ing published: 25 March 2011; accepted:
17 May 2011; published online: 3 May
2011.
Citation:HobbsMM,SparlingPF,Cohen
MS, Shafer WM, Deal CD and Jerse AE
(2011) Experimental gonococcal infec-
tioninmalevolunteers:cumulativeexpe-
rience with Neisseria gonorrhoeae strains
FA1090andMS11mkC.Front.Microbio.
2:123. doi: 10.3389/fmicb.2011.00123
This article was submitted to Frontiers
in Cellular and Infection Microbiology, a
specialty of Frontiers in Microbiology.
Copyright © 2011 Hobbs, Sparling,
Cohen, Shafer, Deal and Jerse. This is
an open-access article subject to a non-
exclusive license between the authors and
Frontiers Media SA, which permits use,
distribution and reproduction in other
forums,providedtheoriginalauthorsand
source are credited and other Frontiers
conditions are complied with.
Frontiers in Microbiology | Cellular and Infection Microbiology May 2011 | Volume 2 | Article 123 | 12
1